STTR Phase II: Compact Aberration Compensated Focus and Scan Control for Biomedical Sensors

STTR 第二阶段：生物医学传感器的紧凑型像差补偿聚焦和扫描控制

• 批准号: 0956910
• 负责人: Brant Kaylor
• 金额: $ 50万
• 依托单位: Bridger Photonics, INC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2013-04-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0956910&HistoricalAwards=false
• 关键词: STTR; Phase; II; Compact; Aberration

This Small Business Technology Transfer (STTR) Phase II project will develop a commercial prototype of an aberration compensated focus control device. This device, based on a MEMS technology, will allow the user to deflect a deformable membrane mirror in a controlled manner in order to select a desired focal length. The device also features active control of low-order aberrations. This technology will enable the next generation of biomedical imaging devices for microscopy applications by enabling focus control and aberration correction in a simple, compact and low-cost sensor.The broader impacts of this research are primarily in biomedical imaging. An industry partner is interested in using the technologys aberration correction capabilities to improve skin cancer detection with their confocal microscopy product line. Microscopy and endomicroscopy researchers at the University of Arizona have stated that this technology will be a valuable asset in their research in the fight against cancer. The company will also team with a recognized leader in MEMS technology to enable enhanced imaging capabilities, primarily for imaging in the field of ophthalmology.

这个小型企业技术转移（STTR）II阶段项目将开发一个畸变补偿焦点控制装置的商业原型。该设备基于MEMS技术，将允许用户以受控方式偏转可变形的膜镜，以选择所需的焦距。该设备还具有低阶畸变的主动控制。这项技术将通过在简单，紧凑和低成本的传感器中实现焦点控制和畸变校正来实现下一代生物医学成像设备，以实现焦点控制和畸变。这项研究的更广泛影响主要在生物医学成像中。一个行业合作伙伴有兴趣使用技术畸变校正能力来通过其共聚焦显微镜产品线改善皮肤癌检测。亚利桑那州大学的显微镜和内运动学研究人员表示，这项技术将是他们在抗癌斗争中的研究中的宝贵资产。该公司还将与MEMS技术公认的领导者合作，以实现增强的成像功能，主要用于在眼科领域进行成像。